Form 4: Vivos Therapeutics Executive Receives Stock Grant
Insider Transaction (Form 4)
Bradford K. Amman, Principal Accounting Officer of Vivos Therapeutics, Inc., reported multiple transactions in common stock on July 31, 2026.
Summary
- Grant/award: acquired 250,000 Common Stock at $0.41 ($102,500) on July 31, 2026; holds 250,080 after (Direct).
- Grant/award: acquired 150,000 Stock Option (Right to Buy) at $0.41 ($61,500) on July 31, 2026; holds 326,533 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Bradford K. Amman — Officer (Principal Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Grant/award | Common Stock | 250,000 | $0 | $102.5K | 250,080 |
| 2026-07-31 | Grant/award | Stock Option (Right to Buy) | 150,000 | $0 | $61.5K | 326,533 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Grant/award (250,000 shares) |
| 2026-07-31 | Grant/award (150,000 shares) |
Keywords
insider transaction, Form 4, VVOS, Vivos Therapeutics, Inc., neutral, Bradford K. Amman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.